World Health Organization Sounds Concern Over Critical Scarcity of Obesity Medications
Under 10% of patients eligible to benefit from obesity jabs like Wegovy can access them, states the World Health Organization as it releases its first guidance on the drugs.
Given over a billion individuals worldwide now classified as obese, it is advocating for increased and just availability to GLP-1 medication.
Based on projections, more than two billion will be living with obesity by 2030 without intervention.
"Our new guidelines acknowledges that excess weight is a lifelong illness that can be addressed with thorough and continuous support," remarked the agency's head Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and distribution challenges are key obstacles to universal access to the injections that can help people shift substantial body mass, says the agency.
Skinny Jab Supply Crisis
Even in the current best projected scenario, the supply of these medications might only reach around 100 million people – less than 10% of the global need, as stated by the WHO.
The recommendation urges countries and companies to expand availability, via measures including licensing agreements.
A patent on semaglutide – the core component of a leading brand – is due to expire in a number of nations in 2026.
How Weight-Loss Injections Operate
The injections imitate a body's own hormone to delay gastric emptying, suppress the appetite and increase feelings of fullness so people reduce food intake.
Individuals commonly see weight reduction in the initial weeks of commencing the once-weekly jabs.
Evidence points to patients may put most of the weight back on after a year of discontinuing the drug, because their typical food cravings return.
Being carrying excess weight raises your chance for contracting diseases, such as diabetes, cardiovascular issues, brain attack, and some malignancies.
Obesity concerns people in countries worldwide and was linked to over three and a half million fatalities worldwide in 2024, as per the WHO.
